Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Laurence De Moerlooze"'
Publikováno v:
Vaccines, Vol 11, Iss 2, p 382 (2023)
Respiratory syncytial virus (RSV) is a common cause of paediatric respiratory tract infection and causes a significant health burden in older adults. Natural immunity to RSV is incomplete, permitting recurrent symptomatic infection over an individual
Externí odkaz:
https://doaj.org/article/4f307928e4364b0f8fa3064cefe80542
Autor:
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 11, Pp 2695-2706 (2017)
Despite the burden of diabetes mellitus (DM), little is known about the role of this and other metabolic syndromes on the severity of hepatitis B virus (HBV) chronicity and liver disease progression. The value of hepatitis B vaccination and its impac
Externí odkaz:
https://doaj.org/article/126a0134c80c43bd90695629fa38d4e3
Autor:
Ilaria Galgani, Eveline M. Bunge, Lisa Hendriks, Christopher Schludermann, Cinzia Marano, Laurence De Moerlooze
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 9, Pp 919-932 (2017)
Introduction: Tick-borne encephalitis (TBE), which is endemic across large regions of Europe and Asia, is most effectively prevented through vaccination. Three-dose primary TBE vaccination schedules are either rapid (0,7,21-days) or conventional (0,2
Externí odkaz:
https://doaj.org/article/4bc6fd79ca594d42828e0d5dc6c99580
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 8, Pp 811-832 (2017)
Introduction: Engerix B (GSK HepB, GSK, Belgium) was the first recombinant hepatitis B virus vaccine to be licensed, and marked its 30th anniversary in 2016. Vaccination of adult populations against HBV is usually implemented on a risk-based approach
Externí odkaz:
https://doaj.org/article/665ef30904d844cebe8821e80f177eba
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 8, Pp 789-809 (2017)
Introduction: The World Health Organization recommends hepatitis B virus (HBV) vaccines to be included in national immunization schedules everywhere, and has adopted the strategic goal of halting viral hepatitis as a major public health threat by 203
Externí odkaz:
https://doaj.org/article/6e829554acd045aaa894dd60920fb77b
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 724-736 (2017)
The WHO recommends integration of universal mass vaccination (UMV) against hepatitis A virus (HAV) in national immunization schedules for children aged ≥1 year, if justified on the basis of acute HAV incidence, declining endemicity from high to int
Externí odkaz:
https://doaj.org/article/2855ecd2272644cf99174a96efa7543f
Autor:
Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P H Meyer, Günter Silbernagl, Rick Nichols, Heinz Weidenthaler, Laurence De Moerlooze, Liddy Chen, Paul Chaplin
Publikováno v:
The Journal of Infectious Diseases. 227:1203-1213
Background Although modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed. Methods Participants naive to smallpox vaccination
Autor:
Elke Jordan, Golam Kabir, Stephanie Schultz, Günter Silbernagl, Darja Schmidt, Victoria A Jenkins, Heinz Weidenthaler, Daria Stroukova, Barbara K Martin, Laurence De Moerlooze
Publikováno v:
The Journal of Infectious Diseases.
Background Respiratory syncytial virus (RSV) causes significant disease burden in older adults. MVA-BN-RSV is a novel poxvirus-vectored vaccine encoding internal and external RSV proteins. Methods In a phase 2a randomized double-blind, placebo-contro
Autor:
Elke Jordan, Golam Kabir, Stephanie Schultz, Günter Silbernagl, Darja Schmidt, Victoria A. Jenkins, Heinz Weidenthaler, Daria Stroukova, Barbara K. Martin, Laurence De Moerlooze
BackgroundRespiratory syncytial virus (RSV) causes significant disease burden in infants and older adults. Most vaccines in development focus on the virus’s F protein. MVA-BN-RSV is a novel vectored vaccine encoding internal and external proteins f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4b0805f60abee5ea9fb8570fc861c04
https://doi.org/10.1101/2022.12.02.22283030
https://doi.org/10.1101/2022.12.02.22283030
Autor:
Heiko, Ilchmann, Nathaly, Samy, Daniela, Reichhardt, Darja, Schmidt, Jacqueline D, Powell, Thomas Ph, Meyer, Günter, Silbernagl, Rick, Nichols, Heinz, Weidenthaler, Laurence, De Moerlooze, Liddy, Chen, Paul, Chaplin
Publikováno v:
The Journal of infectious diseases.
Though Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN®). vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed.Participants naïve to smallpox vaccination were randomized